German American Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$346K Buy
+5,711
New +$333K 0.03% 112
2023
Q4
Sell
-3,462
Closed -$201K 119
2023
Q3
$201K Buy
+3,462
New +$212K 0.03% 110
2023
Q2
Sell
-3,062
Closed -$212K 116
2023
Q1
$212K Hold
3,062
0.03% 113
2022
Q4
$220K Hold
3,062
0.03% 113
2022
Q3
$218K Hold
3,062
0.04% 95
2022
Q2
$236K Sell
3,062
-313
-9% -$23.8K 0.04% 91
2022
Q1
$246K Sell
3,375
-540
-14% -$36.3K 0.04% 88
2021
Q4
$244K Buy
3,915
+99
+3% +$5.81K 0.03% 88
2021
Q3
$226K Sell
3,816
-125
-3% -$8.23K 0.03% 86
2021
Q2
$263K Sell
3,941
-65
-2% -$4.24K 0.04% 82
2021
Q1
$253K Buy
4,006
+303
+8% +$18.9K 0.04% 82
2020
Q4
$230K Buy
3,703
+305
+9% +$18.8K 0.05% 87
2020
Q3
$205K Buy
+3,398
New +$205K 0.05% 75
2020
Q1
Sell
-3,698
Closed -$237K 74
2019
Q4
$237K Buy
+3,698
New +$212K 0.06% 81

Other funds holding BMY

German American Bancorp's BMY Position: Q1 2026 in Review

German American Bancorp opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 5,711 shares worth $346K. The stake represents 0.03% of the portfolio and ranks #112 among its holdings. This is a return to the name: German American Bancorp previously reported a position in BMY as recently as Q3 2023.

German American Bancorp first reported a position in BMY in Q4 2019 and has held it in 14 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • German American Bancorp held 5,711 shares of Bristol-Myers Squibb worth $346K as of Q1 2026.
  • Bristol-Myers Squibb was a new German American Bancorp position in Q1 2026.
  • Bristol-Myers Squibb made up 0.03% of German American Bancorp's portfolio in Q1 2026, its #112 holding.
  • German American Bancorp first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 14 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on German American Bancorp's 13F filing for Q1 2026, filed 6 May 2026.